BackOxford Immunotec Global PLC Overview

Oxford Immunotec Global PLC Total Current Liabilities

Latest total current liabilities for OXFD: $12M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$11.80M
↓ 29.45% YoYΔ $-4.93M vs prior year quarter

Peer trimmed avg / median

Loading

Oxford Immunotec Global PLC Total Current Liabilities History

Loading

Oxford Immunotec Global PLC vs. peers: Total Current Liabilities Comparison

Loading

Oxford Immunotec Global PLC Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Oxford Immunotec Global PLC (OXFD) FAQ

Oxford Immunotec Global PLC (OXFD) currently reports a total current liabilities of $12M as of September 2020. That compares with $17M in the prior-year period — down 29.5% year over year. Use the charts on this page to explore Oxford Immunotec Global PLC's total current liabilities history and peer comparisons.

Oxford Immunotec Global PLC's total current liabilities decreased from $17M to $12M — a 29.5% year-over-year decrease (period ending September 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Oxford Immunotec Global PLC reported $12M in total current liabilities as of September 2020. That compares with $17M in the prior-year period — down 29.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $12M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Oxford Immunotec Global PLC, and consider following OXFD for alerts when major investors trade the stock.

Oxford Immunotec Global PLC is classified in the Healthcare sector. On total current liabilities, it currently shows $12M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OXFD with unrelated industries.